Biovision Technologies, Inc.

Biovision Technologies, Inc., a small business subchapter S corporation based in Downingtown, Pennsylvania, manufactures and supplies precision scientific imaging equipment and microscopy systems to federal research agencies as a prime contractor under total small business set-asides and full-and-open designations. The company operates exclusively as a prime vendor; all 229 awards in its recent federal portfolio are direct prime contracts with no subcontract footprint.

Biovision's customer base concentrates heavily within the National Institutes of Health research complex under the Department of Health and Human Services. The top five customer entities account for 38% of awards and 48% of combined potential value, anchored by the National Cancer Institute (29 awards, $1 million combined potential value), the National Institute on Drug Abuse (14 awards, $591 thousand), the National Heart, Lung and Blood Institute (20 awards, $539 thousand), and the National Institute of Environmental Health Sciences (11 awards, $255 thousand). The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 rounds out the top tier by potential value with two awards worth $254 thousand. Biovision has served 37 distinct federal customer agencies across NIH institutes, the VA, and the National Institute of Standards and Technology.

The company's capability portfolio centers on laboratory imaging equipment and precision optical instrumentation for biomedical research. Representative recent work includes a $22,564 total small business set-aside purchase order from the National Cancer Institute awarded July 31, 2026 for a Tokai Hit stagetop incubator control system with temperature, humidity, and CO2 monitoring capability and installation services; an $84,445 total small business set-aside purchase order from the Warner Robins Air Logistics Complex awarded July 24, 2025 for a metrology-grade QCMOS digital camera with single-photon measurement capability fulfilling an original NIST sources-sought notice; a $43,800 total small business set-aside purchase order from the VA West Los Angeles Healthcare System awarded December 12, 2024 for a Hamamatsu Orca Quest qCMOS digital camera kit; and a $30,500 total small business set-aside purchase order from the National Heart, Lung and Blood Institute awarded August 30, 2023 for a Teledyne Photometrics Prime 95B camera. Work spans digital cameras, stage-top incubators, illumination systems, linear encoders, and microscope workstations — equipment supporting live-cell imaging, fluorescence microscopy, and biomedical visualization across NIH research programs.

Activity has declined sharply. The portfolio peaked at four awards in 2022, dropping to three in 2023, one in 2024, one in 2025, and two through July 2026. Only two awards (combined potential value $42 thousand) complete within the next twenty-four months, presenting minimal recompete exposure. The vendor's purchase orders flow through NIH and VA blanket purchase agreements; the portfolio lists five BPAs by number with single task orders each, indicating fractional utilization. NAICS concentration aligns with the equipment profile: Analytical Laboratory Instrument Manufacturing accounts for 124 of 229 awards, with Optical Instrument and Lens Manufacturing (12 awards) and laboratory-related services categories representing the remainder. The company has served federal agencies since at least 1999 and holds an established track record supplying imaging technologies to NIH and VA research laboratories.